Dr. Sklavenitis Pistofidis spoke to Blood Cancers Today about the need for new diagnostic assays that can be performed on blood samples and can provide multiple layers of accurate and prognostically relevant information, and highlighted the role SWIFT-seq could play in the experience of patients with Multiple Myeloma.
